From exposures to population interventions: Pregnancy and response to HIV therapy

American Journal of Epidemiology

Volumn 179, Issue 7, 2014, Pages 797-806

  Westreich, Daniel ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

causal inference; generalized impact fraction; implementation science; population attributable fraction; population intervention effects

Indexed keywords

ANTIRETROVIRUS AGENT; MEDROXYPROGESTERONE ACETATE;

DATA SET; HEALTH POLICY; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE SYSTEM; MAGNITUDE; POLICY MAKING; POPULATION STRUCTURE; PREGNANCY; PUBLIC HEALTH;

ADULT; ARTICLE; BODY MASS; CD4 LYMPHOCYTE COUNT; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGICAL DATA; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN EXPERIMENT; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LONGITUDINAL STUDY; METHODOLOGY; MIDDLE AGED; PARAMETRIC TEST; POPULATION RESEARCH; PREGNANCY; SOUTH AFRICA; TREATMENT RESPONSE; VIRUS LOAD; YOUNG ADULT;

SOUTH AFRICA;

HUMAN IMMUNODEFICIENCY VIRUS;

CAUSAL INFERENCE; GENERALIZED IMPACT FRACTION; IMPLEMENTATION SCIENCE; POPULATION ATTRIBUTABLE FRACTION; POPULATION INTERVENTION EFFECTS;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CONTRACEPTION; DATA INTERPRETATION, STATISTICAL; FEMALE; HIV INFECTIONS; HUMANS; LIKELIHOOD FUNCTIONS; LONGITUDINAL STUDIES; MONTE CARLO METHOD; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK FACTORS; SOUTH AFRICA; TIME FACTORS; VIRAL LOAD;

EID: 84896925202     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwt328     Document Type: Article

References (61)

1. Hernán MA, Robins JM. Estimating causal effects from epidemiological data. J Epidemiol Community Health. 2006; 60(7):578-586.
2. Mortimer KM, Neugebauer R, van der Laan M, et al. An application of model-fitting procedures for marginal structural models. Am J Epidemiol. 2005;162(4):382-388.
3. Cole SR, Hernán M.A. Constructing inverse probability weights for marginal structural models. Am J Epidemiol. 2008;168(6): 656-664.
4. Westreich D, Cole S.R. Invited commentary: positivity in practice. Am J Epidemiol. 2010;171(6):674-677.
5. Cole SR, Frangakis CE. The consistency statement in causal inference: a definition or an assumption? Epidemiology. 2009; 20(1):3-5.
6. Vander Weele TJ. Concerning the consistency assumption in causal inference. Epidemiology. 2009;20(6):880-883.
7. Hernán MA, Vander Weele TJ. Compound treatments and transportability of causal inference. Epidemiology. 2011;22(3): 368-377.
8. Robins JM, Hernán MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology. 2000;11(5):550-560.
9. Hernán MA, Brumback B, Robins JM. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology. 2000;11(5):561-570.
10. Robins J. A graphical approach to the identification and estimation of causal parameters in mortality studies with sustained exposure periods. J Chronic Dis. 1987;40(suppl 2): 139S-161S.
11. Taubman SL, Robins JM, Mittleman MA, et al. Intervening on risk factors for coronary heart disease: an application of the parametric g-formula. Int J Epidemiol. 2009;38(6): 1599-1611.
12. Westreich D, Cole SR, Young JG, et al. The parametric g-formula to estimate the effect of highly active antiretroviral therapy on incident AIDS or death. Stat Med. 2012;31(18):2000-2009.
13. Westreich D, Cole SR, Nagar S, et al. Pregnancy and virologic response to antiretroviral therapy in South Africa. PLoS One. 2011;6(8):e22778.
14. Cole SR, Hernán MA, Robins JM, et al. Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models. Am J Epidemiol. 2003;158(7):687-694.
15. Hernán MA, Cole SR, Margolick J, et al. Structural accelerated failure time models for survival analysis in studies with time-varying treatments. Pharmacoepidemiol Drug Saf. 2005; 14(7):477-491.
16. Poole C. Generalized effect estimation: an antidote to utopian preventive fantasies [abstract]. Am J Epidemiol. 2003; 157(suppl):S59.
17. Hubbard AE, van der Laan MJ. Population intervention models in causal inference. Biometrika. 2008;95(1):35-47.
18. Ahern J, Hubbard A, Galea S. Estimating the effects of potential public health interventions on population disease burden: a step-by-step illustration of causal inference methods. Am J Epidemiol. 2009;169(9):1140-1147.
19. Khoury MJ, Gwinn M, Ioannidis JP. The emergence of translational epidemiology: from scientific discovery to population health impact. Am J Epidemiol. 2010;172(5): 517-524.
20. Levin ML. The occurrence of lung cancer in man. Acta Unio Int Contra Cancrum. 1953;9(3):531-541.
21. Cole P, MacMahon B. Attributable risk percent in case-control studies. Br J Prev Soc Med. 1971;25(4):242-244.
22. Miettinen OS. Proportion of disease caused or prevented by a given exposure, trait or intervention. Am J Epidemiol. 1974; 99(5):325-332.
23. Sturmans F, Mulder PG, Valkenburg HA. Estimation of the possible effect of interventive measures in the area of ischemic heart diseases by the attributable risk percentage. Am J Epidemiol. 1977;105(3):281-289.
24. Ouellet BL, Romeder JM, Lance JM. Premature mortality attributable to smoking and hazardous drinking in Canada. Am J Epidemiol. 1979;109(4):451-463.
25. Deubner DC, Wilkinson WE, Helms MJ, et al. Logistic model estimation of death attributable to risk factors for cardiovascular disease in Evans County, Georgia. Am J Epidemiol. 1980; 112(1):135-143.
26. Wacholder S. The impact of a prevention effort on the community. Epidemiology. 2005;16(1):1-3.
27. Greenland S, Robins JM. Conceptual problems in the definition and interpretation of attributable fractions. Am J Epidemiol. 1988;128(6):1185-1197.
28. Walter SD. Prevention for multifactorial diseases. Am J Epidemiol. 1980;112(3):409-416.
29. Morgenstern H, Bursic ES. A method for using epidemiologic data to estimate the potential impact of an intervention on the health status of a target population. J Community Health. 1982; 7(4):292-309.
30. Martire KA, Mattick RP, Doran CM, et al. Cigarette tax and public health: what are the implications of financially stressed smokers for the effects of price increases on smoking prevalence? Addiction. 2011;106(3):622-630.
31. Ouellet RP, Apostolides AY, Entwisle G, et al. Estimated community impact of hypertension control in a high risk population. Am J Epidemiol. 1979;109(5):531-538.
32. Browner WS. Estimating the impact of risk factor modification programs. Am J Epidemiol. 1986;123(1):143-153.
33. Siu AL, McGlynn EA, Morgenstern H, et al. Choosing quality of care measures based on the expected impact of improved care on health. Health Serv Res. 1992;27(5):619-650.
34. Bulterys M, Morgenstern H, Weed DL. Quantifying the expected vs potential impact of a risk-factor intervention program. Am J Public Health. 1997;87(5):867-868.
35. Strachan D, Rose G. Strategies of prevention revisited: effects of imprecise measurement of risk factors on the evaluation of "high-risk" and "population-based" approaches to prevention of cardiovascular disease. J Clin Epidemiol. 1991;44(11): 1187-1196.
36. Muñoz ID, van der Laan M. Population intervention causal effects based on stochastic interventions. Biometrics. 2012; 68(2):541-549.
37. Cain LE, Robins JM, Lanoy E, et al. When to start treatment? A systematic approach to the comparison of dynamic regimes using observational data. Int J Biostat. 2010;6(2):Article 18.
38. Danaei G, Pan A, Hu FB, et al. Hypothetical midlife interventions in women and risk of type 2 diabetes. Epidemiology. 2013;24(1):122-128.
39. Cole SR, Richardson DB, Chu H, et al. Analysis of occupational asbestos exposure and lung cancer mortality using the G formula. Am J Epidemiol. 2013;177(9):989-996.
40. Greenland S, Drescher K. Maximum likelihood estimation of the attributable fraction from logistic models. Biometrics. 1993; 49(3):865-872.
41. Sjölander A, Vansteelandt S. Doubly robust estimation of attributable fractions. Biostatistics. 2011;12(1):112-121.
42. Sjölander A. Estimation of attributable fractions using inverse probability weighting. Stat Methods Med Res. 2011;20(4): 415-428.
43. Taguri M, Matsuyama Y, Ohashi Y, et al. Doubly robust estimation of the generalized impact fraction. Biostatistics. 2012;13(3):455-467.
44. Robins JM. A new approach to causal inference in mortality studies with a sustained exposure periods-application to control of the healthy worker survivor effect. Math Model. 1986;7(9-12):1393-1512.
45. Wacholder S. The case-control study as data missing by design: estimating risk differences. Epidemiology. 1996;7(2):144-150.
46. Poole C. On the origin of risk relativism. Epidemiology. 2010; 21(1):3-9.
47. Riddler SA, Haubrich R, DiRienzo AG, et al. Class-sparing regimens for initial treatment of HIV-1 infection. N Engl J Med. 2008;358(20):2095-2106.
48. Splawa-Neyman J. On the application of probability theory to agricultural experiments. Essay on principles. Section 9. [Translated and edited by D. M. Dabrowska and T. P. Speed from the Polish original, which appeared in Roczniki Nauk Rolniczych Tom X (1923) 1-51 (Annals of Agricultural Sciences)]. Stat Sci. 1990;5(4):465-472.
49. Rubin DB. Estimating causal effects of treatments in randomized and nonrandomized studies. J Educ Psychol. 1974; 66(5):688-701.
50. Westreich D, Cole SR, Tien PC, et al. Time scale and adjusted survival curves for marginal structural Cox models. Am J Epidemiol. 2010;171(6):691-700.
51. Cain LE, Cole S.R. Inverse probability-of-censoring weights for the correction of time-varying noncompliance in the effect of randomized highly active antiretroviral therapy on incident AIDS or death. Stat Med. 2009;28(12):1725-1738.
52. South Africa Department of Health, Medical Research Council, ORC Macro (Macro International Inc.). South Africa Demographic and Health Survey 2003. Pretoria, South Africa: South Africa Department of Health; 2007.
53. Morrison CS, Skoler-Karpoff S, Kwok C, et al. Hormonal contraception and the risk of HIV acquisition among women in South Africa. AIDS. 2012;26(4):497-504.
54. Schwartz SR, Rees H, Mehta S, et al. High incidence of unplanned pregnancy after antiretroviral therapy initiation: findings from a prospective cohort study in South Africa. PLoS One. 2012;7(4):e36039.
55. Stang A, Poole C, Bender R. Common problems related to the use of number needed to treat. J Clin Epidemiol. 2010;63(8): 820-825.
56. Schackman BR. Implementation science for the prevention and treatment of HIV/AIDS. J Acquir Immune Defic Syndr. 2010; 55(suppl 1):S27-S31.
57. Miettinen OS. Causal and preventive interdependence. Elementary principles. Scand J Work Environ Health. 1982; 8(3):159-168.
58. Greenland S, Robins JM. Identifiability, exchangeability, and epidemiological confounding. Int J Epidemiol. 1986;15(3): 413-419.
59. Hernán MA, Taubman SL. Does obesity shorten life? The importance of well-defined interventions to answer causal questions. Int J Obes (Lond). 2008;32(suppl 3): S8-S14.
60. Watts DH, Park JG, Cohn SE, et al. Safety and tolerability of depot medroxyprogesterone acetate among HIV-infected women on antiretroviral therapy: ACTG A5093. Contraception. 2008;77(2):84-90.
61. Robins J, Hernán M. Estimation of the causal effects of time-varying exposures. In: Fitzmaurice G, Davidian M, Verbeke G, et al., eds. Longitudinal Data Analysis. Boca Raton, FL: CRC Press; 2008:553-599.